Vancouver Coastal Health has launched British Columbia’s first dedicated inpatient clinical trials unit for early-phase therapies in blood cancers. Located at Vancouver General Hospital (VGH), the new Hematology Research Unit will deliver revolutionary therapies — including first-in-human treatments such as advanced immunotherapies like CAR T-cell therapy — to patients with relapsed or treatment-resistant hematological diseases.
Embedded within the renowned Leukemia/Bone Marrow Transplant (BMT) Program of BC, the Hematology Research Unit is purpose-built to support complex clinical trials that require expert collaboration among hematologists, critical care teams, specialized nurses, and allied health professionals. Early-phase trials typically demand intensive monitoring and support beyond what usual clinical care settings can safely provide.
